Delivery Order SPE2DB22D2206-SPE2DB25FJE22
Award Date 7/31/25
Potential Completion Date 8/1/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Xcopri 100 mg tablets (30-count units) with a ceiling value of $2,947.40. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The contract has an ultimate completion date of July 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Xcopri 50 mg tablets (30-count) with a ceiling value of $2,070.10. This competitive award utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract carries no set-aside designation, indicating it...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,768.44 for XCOPRI 150 mg tablets (30-count units) with an ultimate completion date of July 24, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The award leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, a...
- The Defense Logistics Agency awarded a $2,232.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Xcopri 200 mg on July 28, 2025, with completion targeted for July 29, 2025. This non-set-aside contract represents a pharmaceutical supply delivery to support federal medical procurement needs, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $4,330.58 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Xcopri 50 mg tablets (30-count). This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 31, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. AmerisourceBergen Drug Corp, a major pharmaceutical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of the prescription medication Xcopri (cenobamate) 50 mg tablets. The contract has a ceiling value of $4,903.86 and a period of performance through April 21, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp, headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $1,460.27 to AmerisourceBergen Drug Corp for 30-count tablets of Xcopri 150 mg, a medication primarily used in treating certain seizure disorders. This competitively awarded, firm fixed-price delivery order was issued on July 22, 2025, with an ultimate completion date of July 23, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $1,102.21 to AmerisourceBergen Drug Corp for XCOPRI 50-100 mg Titration Pak (28 count) on July 30, 2025, with an ultimate completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. XCOPRI (cenobamate) is an anticonvulsant medication used to treat seizure disorders, and this delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,012.37 to AmerisourceBergen Drug Corp for 30 tablets of Xcopri 50 mg, a pharmaceutical product, with performance to be completed by July 22, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is...
- The Defense Logistics Agency awarded a $1,178.96 delivery order to AmerisourceBergen Drug Corp for XCOPRI 100 mg tablets (30-count units) under a firm fixed price contract with a completion date of July 22, 2025. This non-set-aside award was competitively awarded and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The order represents a child contract action under AmerisourceBergen's larger federal pharmaceutical supply arrangement with DLA....